The effect of Action Observation on gait of persons with multiple sclerosis (MS)

The effect of Action Observation therapy (AOT) on balance and kinematic parameters of gait in patients with multiple sclerosis.

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT20220613055155N1

Enrollment

Registered

2022-11-12

Start date

2023-02-20

Completion date

Unknown

Last updated

2022-11-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Multiple Sclerosis. Multiple sclerosis

Interventions

Intervention 1: Action observation intervention group: This group includes 12 patients with MS who are included in the study based on the inclusion criteria. In the first stage, the subjects of this g

Eligibility

Sex/Gender

All

Age

18 Years to 45 Years

Inclusion criteria

Inclusion criteria: Diagnosis of spastic primary progressive, secondary progressive, relapsing-remitting MS Extensive Disability Status Scale (EDSS) Score between 3 and 6 Mini–mental state examination (MMSE) test score more than 24

Exclusion criteria

Exclusion criteria: Recurrence of MS during 3 months before intervention Pregnancy and lactation Having a psychiatric disorder or drug / alcohol abuse Inability to sit without torso support Inability to stand for at least 10 seconds with support Other neurological or orthopedic diseases of the lower extremities (musculoskeletal diseases, severe osteoarthritis, peripheral neuropathy, joint replacement) Cardiovascular diseases (recent myocardial infarction, heart failure, uncontrolled hypertension, orthostatic hypotension) participation in other clinical studies

Design outcomes

Primary

Measure	Time frame
The center of pressure velocity (COPV). Timepoint: at the beginning of the study (before the start of the intervention), after the end of the intervention (6 weeks after the start of the intervention) and one month after the end of the intervention. Method of measurement: Force plate.;Step length. Timepoint: At the beginning of the study (before the start of the intervention), after the end of the intervention (6 weeks after the start of the intervention), and one month after the end of the intervention. Method of measurement: 3D Motion capture cameras and gait analyzing system.;Step width. Timepoint: At the beginning of the study (before the start of the intervention), after the end of the intervention (6 weeks after the start of the intervention), and one month after the end of the intervention. Method of measurement: 3D Motion capture cameras and gait analyzing system.;Step time. Timepoint: At the beginning of the study (before the start of the intervention), after the end of the intervention (6 weeks after the start of the intervention) and one month after the end of the intervention. Method of measurement: 3D Motion capture cameras and gait analyzing system.;Gait velocity (meters per second). Timepoint: At the beginning of the study (before the start of the intervention), after the end of the intervention (6 weeks after the start of the intervention) and one month after the end of the intervention. Method of measurement: 3D Motion capture cameras and gait analyzing system.;Stride length. Timepoint: At the beginning of the study (before the start of the intervention), after the end of the intervention (6 weeks after the start of the intervention) and one month after the end of the intervention. Method of measurement: 3D Motion capture cameras and gait analyzing system.;Stride time. Timepoint: At the beginning of the study (before the start of the intervention), after the end of the intervention (6 weeks after the start of the intervention) and one month after th	—

Measure

Time frame

The center of pressure velocity (COPV). Timepoint: at the beginning of the study (before the start of the intervention), after the end of the intervention (6 weeks after the start of the intervention) and one month after the end of the intervention. Method of measurement: Force plate.;Step length. Timepoint: At the beginning of the study (before the start of the intervention), after the end of the intervention (6 weeks after the start of the intervention), and one month after the end of the intervention. Method of measurement: 3D Motion capture cameras and gait analyzing system.;Step width. Timepoint: At the beginning of the study (before the start of the intervention), after the end of the intervention (6 weeks after the start of the intervention), and one month after the end of the intervention. Method of measurement: 3D Motion capture cameras and gait analyzing system.;Step time. Timepoint: At the beginning of the study (before the start of the intervention), after the end of the intervention (6 weeks after the start of the intervention) and one month after the end of the intervention. Method of measurement: 3D Motion capture cameras and gait analyzing system.;Gait velocity (meters per second). Timepoint: At the beginning of the study (before the start of the intervention), after the end of the intervention (6 weeks after the start of the intervention) and one month after the end of the intervention. Method of measurement: 3D Motion capture cameras and gait analyzing system.;Stride length. Timepoint: At the beginning of the study (before the start of the intervention), after the end of the intervention (6 weeks after the start of the intervention) and one month after the end of the intervention. Method of measurement: 3D Motion capture cameras and gait analyzing system.;Stride time. Timepoint: At the beginning of the study (before the start of the intervention), after the end of the intervention (6 weeks after the start of the intervention) and one month after th

—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMisagh Rahimi

Shiraz University of Medical Sciences

Misaghrahimi1995@gmail.com+98 71 3627 1551

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026